Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technology

25 Mar 2021

Abstract excerpt

Insulin resistance (IR) is associated with several metabolic disorders, including type 2 diabetes (T2D). The development of IR in insulin target tissues involves genetic and acquired factors. Persons at genetic risk for T2D tend to develop IR several years before glucose intolerance. Several rodent models for both IR and T2D are being used to study the disease pathogenesis; however, these models cannot...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to Pancreatic function and diabetes
Share to Pluripotent Stem Cells Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33815671
DOI: 10.4252/wjsc.v13.i3.221

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Insulin resistance in diabetes: The promise of using induced pluripotent stem cell technologyPMID 33815671Read ↗

Insulin Resistance in Diabetes: The Promise of Using Induced Pluripotent Stem Cell TechnologySemantic proximity Read ↗

Human-Induced Pluripotent Stem Cells (iPSCs) for Disease Modeling and Insulin Target Cell Regeneration in the Treatment of Insulin Resistance: A ReviewSemantic proximity Read ↗

Toward Precision Medicine with Human Pluripotent Stem Cells for DiabetesSemantic proximity Read ↗

Human Pluripotent Stem Cells to Model Islet Defects in Diabetes.Semantic proximity Read ↗

Monogenic Diabetes Modeling: In Vitro Pancreatic Differentiation From Human Pluripotent Stem Cells Gains MomentumSemantic proximity Read ↗

Modeling physiological insulin sensitivity and pre-diabetic insulin resistance in multiple hPSC-derived cell typesSemantic proximity Read ↗

The prospect of induced pluripotent stem cells for diabetes mellitus treatmentSemantic proximity Read ↗

Potential of pluripotent stem cells for diabetes therapy.Semantic proximity Read ↗

Human Pluripotent Stem Cells Go Diabetic: A Glimpse on Monogenic Variants.Semantic proximity Read ↗

Genetic Insulin Resistance Is a Potent Regulator of Gene Expression and Proliferation in Human iPS CellsSemantic proximity Read ↗

Modeling Maturity Onset Diabetes of the Young in Pluripotent Stem Cells: Challenges and Achievements.Semantic proximity Read ↗

Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.